Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investors Events
  • Pre market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
April 5, 2022 7:28 AM 2 min read

Tesla Bear Michael Burry Says Elon Musk Taking Controlling Stake In Twitter Would Be 'Good For America'

by Shivdeep Dhaliwal Benzinga Editor
Follow

ArticleFeaturedTickersList12345!!!

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk's buying of Twitter Inc (NASDAQ: TSLA) shares has prompted a comment from his usual detractor — hedge fund manager and investor Michael Burry.

What Happened: Burry said on Twitter that Musk “buying enough shares to control Twitter would be good for America. Period.”The “Big Short” fame investor in his post shared a Boston Herald editorial that criticized major news outlets' coverage of Hunter Biden, the son of U.S. President Joe Biden. 

The Herald’s piece hit out at The New York Times, The Washington Post for admitting very late that "Hunter Biden is a train wreck."

It also said the Associated Press, which runs a feature called “Not Real News: A Look at What Didn’t Happen," needed to "stop trying to be the voice of America and just chase down the news."

See Also: How To Buy Tesla (TSLA) Stock

Why It Matters:  In 2020, both Twitter and Meta Platforms Inc’s (NASDAQ: FB) Facebook faced flak over limiting a New York Post story on Biden, whose son Hunter introduced him to a Ukrainian businessman while he was still vice president. The article was based on email and data extracted from a laptop left at a Delaware repair shop.

At the time, the then Twitter CEO, Jack Dorsey, admitted that company's communication and action on the Post’s article were "not great.”

Last month, Musk tweeted about the “de facto” bias in Twitter’s algorithm and said he was worried about the effect it has on public discourse. 

Burry, who uses “Cassandra” as a pen name on Twitter, has clashed with Musk in the past and bet against Tesla but has said he is no longer shorting the company. The famed short seller rarely provides context around his tweets and it isn't immediately clear if his comment was made in jest.

Price Action: Twitter shares soared 27% to $49.93 in the regular session on Monday and appreciated 1.2% to $50.52 in the after-hours trading. On the same day, Tesla shares closed 5.6% higher at $1,145.45 in the regular session, according to data from Benzinga Pro.

See Also: 'The Big Short' Fame's Michael Burry Says 'Glad' He Never Got The Opportunity To Use His Disability 'As An Excuse'

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


Posted In:
NewsSocial MediaGeneralElon MuskHunter BidenJoe BidenMichael Burry
FB Logo
FBProShares S&P 500 Dynamic Buffer ETF
$41.72-1.57%
Overview
TSLA Logo
TSLATesla Inc
$438.601.65%
FB Logo
FBProShares S&P 500 Dynamic Buffer ETF
$41.72-1.57%
Overview
TSLA Logo
TSLATesla Inc
$438.601.65%
Comments
Loading...